Search Results - "DIKEN, Mustafa"

Refine Results
  1. 1
  2. 2
  3. 3

    Specific hepatic delivery of procollagen α1(I) small interfering RNA in lipid‐like nanoparticles resolves liver fibrosis by Jiménez Calvente, Carolina, Sehgal, Alfica, Popov, Yury, Kim, Yong Ook, Zevallos, Victor, Sahin, Ugur, Diken, Mustafa, Schuppan, Detlef

    Published in Hepatology (Baltimore, Md.) (01-10-2015)
    “…Fibrosis accompanies the wound‐healing response to chronic liver injury and is characterized by excessive hepatic collagen accumulation dominated by collagen…”
    Get full text
    Journal Article
  4. 4

    Exploiting the Mutanome for Tumor Vaccination by CASTLE, John C, KREITER, Sebastian, KOSLOWSKI, Michael, KUHN, Andreas N, BRITTEN, Cedrik M, HUBER, Christoph, TÜRECI, Ozlem, SAHIN, Ugur, DIEKMANN, Jan, LÖWER, Martin, DE ROEMER, Niels Van, DE GRAAF, Jos, SELMI, Abderraouf, DIKEN, Mustafa, BOEGEL, Sebastian, PARET, Claudia

    Published in Cancer research (Chicago, Ill.) (01-03-2012)
    “…Multiple genetic events and subsequent clonal evolution drive carcinogenesis, making disease elimination with single-targeted drugs difficult. The multiplicity…”
    Get full text
    Journal Article
  5. 5

    Immunomic, genomic and transcriptomic characterization of CT26 colorectal carcinoma by Castle, John C, Loewer, Martin, Boegel, Sebastian, de Graaf, Jos, Bender, Christian, Tadmor, Arbel D, Boisguerin, Valesca, Bukur, Thomas, Sorn, Patrick, Paret, Claudia, Diken, Mustafa, Kreiter, Sebastian, Türeci, Özlem, Sahin, Ugur

    Published in BMC genomics (13-03-2014)
    “…Tumor models are critical for our understanding of cancer and the development of cancer therapeutics. Here, we present an integrated map of the genome,…”
    Get full text
    Journal Article
  6. 6

    Reductive Decationizable Block Copolymers for Stimuli-Responsive mRNA Delivery by Nuhn, Lutz, Kaps, Leonard, Diken, Mustafa, Schuppan, Detlef, Zentel, Rudolf

    Published in Macromolecular rapid communications. (01-06-2016)
    “…Messenger ribonucleic acids (mRNAs) are considered as promising alternatives for transient gene therapy, but to overcome their poor pharmacokinetic properties,…”
    Get full text
    Journal Article
  7. 7

    HPV16 RNA-LPX vaccine mediates complete regression of aggressively growing HPV-positive mouse tumors and establishes protective T cell memory by Grunwitz, Christian, Salomon, Nadja, Vascotto, Fulvia, Selmi, Abderaouf, Bukur, Thomas, Diken, Mustafa, Kreiter, Sebastian, Türeci, Özlem, Sahin, Ugur

    Published in Oncoimmunology (02-09-2019)
    “…HPV16 infections are associated with a variety of cancers and there is compelling evidence that the transforming activity of HPV16 critically depends on the…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Tumor vaccination using messenger RNA: prospects of a future therapy by Kreiter, Sebastian, Diken, Mustafa, Selmi, Abderraouf, Türeci, Özlem, Sahin, Ugur

    Published in Current opinion in immunology (01-06-2011)
    “…Highlights ► Coding mRNA is emerging as an attractive option for antitumor vaccination. ► mRNA not only serves as an antigen format but also has an intrinsic…”
    Get full text
    Journal Article
  10. 10
  11. 11

    FBXO32 promotes microenvironment underlying epithelial-mesenchymal transition via CtBP1 during tumour metastasis and brain development by Sahu, Sanjeeb Kumar, Tiwari, Neha, Pataskar, Abhijeet, Zhuang, Yuan, Borisova, Marina, Diken, Mustafa, Strand, Susanne, Beli, Petra, Tiwari, Vijay K.

    Published in Nature communications (15-11-2017)
    “…The set of events that convert adherent epithelial cells into migratory cells are collectively known as epithelial–mesenchymal transition (EMT). EMT is…”
    Get full text
    Journal Article
  12. 12

    Artificial intelligence and neoantigens: paving the path for precision cancer immunotherapy by Bulashevska, Alla, Nacsa, Zsófia, Lang, Franziska, Braun, Markus, Machyna, Martin, Diken, Mustafa, Childs, Liam, König, Renate

    Published in Frontiers in immunology (29-05-2024)
    “…Cancer immunotherapy has witnessed rapid advancement in recent years, with a particular focus on neoantigens as promising targets for personalized treatments…”
    Get full text
    Journal Article
  13. 13

    CRISPR/Cas9-mediated TGFβRII disruption enhances anti-tumor efficacy of human chimeric antigen receptor T cells in vitro by Alishah, Khadijeh, Birtel, Matthias, Masoumi, Elham, Jafarzadeh, Leila, Mirzaee, Hamid Reza, Hadjati, Jamshid, Voss, Ralf-Holger, Diken, Mustafa, Asad, Sedighe

    Published in Journal of translational medicine (27-11-2021)
    “…CAR T-cell therapy has been recently unveiled as one of the most promising cancer therapies in hematological malignancies. However, solid tumors mount a…”
    Get full text
    Journal Article
  14. 14

    A liposomal RNA vaccine inducing neoantigen-specific CD4+ T cells augments the antitumor activity of local radiotherapy in mice by Salomon, Nadja, Vascotto, Fulvia, Selmi, Abderaouf, Vormehr, Mathias, Quinkhardt, Juliane, Bukur, Thomas, Schrörs, Barbara, Löewer, Martin, Diken, Mustafa, Türeci, Özlem, Sahin, Ugur, Kreiter, Sebastian

    Published in Oncoimmunology (01-01-2020)
    “…Antigen-encoding, lipoplex-formulated RNA (RNA-LPX) enables systemic delivery to lymphoid compartments and selective expression in resident antigen-presenting…”
    Get full text
    Journal Article
  15. 15

    MC38 colorectal tumor cell lines from two different sources display substantial differences in transcriptome, mutanome and neoantigen expression by Schrörs, Barbara, Hos, Brett J, Yildiz, Ikra G, Löwer, Martin, Lang, Franziska, Holtsträter, Christoph, Becker, Julia, Vormehr, Mathias, Sahin, Ugur, Ossendorp, Ferry, Diken, Mustafa

    Published in Frontiers in immunology (08-03-2023)
    “…The cell line MC38 is a commonly used murine model for colorectal carcinoma. It has a high mutational burden, is sensitive to immune checkpoint immunotherapy…”
    Get full text
    Journal Article
  16. 16

    Polysarcosine-Functionalized mRNA Lipid Nanoparticles Tailored for Immunotherapy by Wilhelmy, Christoph, Keil, Isabell Sofia, Uebbing, Lukas, Schroer, Martin A., Franke, Daniel, Nawroth, Thomas, Barz, Matthias, Sahin, Ugur, Haas, Heinrich, Diken, Mustafa, Langguth, Peter

    Published in Pharmaceutics (01-08-2023)
    “…Lipid nanoparticles (LNPs) have gained great attention as carriers for mRNA-based therapeutics, finding applications in various indications, extending beyond…”
    Get full text
    Journal Article
  17. 17
  18. 18
  19. 19

    Molecular in vivo imaging of gastric cancer in a human-murine xenograft model: targeting epidermal growth factor receptor by Hoetker, Michael S, Kiesslich, Ralf, MD, Diken, Mustafa, PhD, Moehler, Markus, MD, Galle, Peter R., MD, Li, Yanqing, MD, Goetz, Martin, MD

    Published in Gastrointestinal endoscopy (01-09-2012)
    “…Background The prognosis of gastric cancer depends on early diagnosis. Targeted therapies against epidermal growth factor receptors (EGFRs) are currently…”
    Get full text
    Journal Article
  20. 20